Inception Return
(6/5/2020)
|
20.02 %
|
|
YTD Return
|
1.04 %
|
|
NAVPS
(2/20/2026)
|
$22.86
|
|
Change
|
$0.12 / 0.52 %
|
|
|
Growth of $10,000
(As of January 31, 2026)
|
|
MER
|
0.41 %
|
|
Assets ($mil)
|
-
|
|
Rank (1Yr)
|
6/1302
|
|
Std Dev (3Yr)
|
-
|
|
Volatility Ranking (3Yr)
|
8/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
Fidelity U.S. Value Currency Neutral Index ETF seeks to replicate, to the extent reasonably possible and before fees and expenses, the performance of the Fidelity Canada U.S. Value Currency Neutral Index. This Fidelity ETF invests primarily in equity securities of large and mid-capitalization U.S. companies that have attractive valuation and uses derivatives to try to minimize the exposure of currency fluctuations between the U.S. and Canadian dollars.
|
Fund Manager
Fidelity Investments Canada ULC
Portfolio Manager
James Wittebol, Fidelity Investments Canada ULC
Aaron Hurd, Fidelity Investments Canada ULC
Yunus Ayaz, Fidelity Investments Canada ULC
Matthew Fonteneau, Fidelity Investments Canada ULC
Sub-Advisor
Geode Capital Management, LLC
State Street Global Advisors Ltd.
|
|
Asset Allocation
(As of December 31, 2025)
|
Sector Allocation
(As of December 31, 2025)
|
Geographic Allocation
(As of December 31, 2025)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Alcoa Corp | US Equity | Basic Materials | United States | 0.00% |
| Newmont Corp | US Equity | Basic Materials | United States | 0.00% |
| NVIDIA Corp | US Equity | Technology | United States | 0.00% |
| Apple Inc | US Equity | Technology | United States | 0.00% |
| Microsoft Corp | US Equity | Technology | United States | 0.00% |
| Edison International | US Equity | Utilities | United States | 0.00% |
| PG&E Corp | US Equity | Utilities | United States | 0.00% |
| Eli Lilly and Co | US Equity | Healthcare | United States | 0.00% |
| Berkshire Hathaway Inc Cl B | US Equity | Financial Services | United States | 0.00% |
| Johnson & Johnson | US Equity | Healthcare | United States | 0.00% |
Performance Data
(As of January 31, 2026)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
1.04
|
7.49
|
18.65
|
1.04
|
18.20
|
19.93
|
19.26
|
-
|
|
Benchmark
|
0.38
|
-1.55
|
7.89
|
0.38
|
8.94
|
21.75
|
16.36
|
15.23
|
|
Quartile Ranking
|
2
|
1
|
1
|
2
|
1
|
2
|
1
|
-
|
|
Calendar Return (%)
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
Fund
|
22.38
|
24.26
|
20.63
|
-4.79
|
36.81
|
-
|
-
|
-
|
-
|
-
|
|
Benchmark
|
12.28
|
36.01
|
23.32
|
-12.52
|
28.16
|
16.07
|
25.18
|
3.98
|
13.80
|
8.65
|
|
Quartile Ranking
|
1
|
3
|
3
|
1
|
1
|
-
|
-
|
-
|
-
|
-
|